Rock Springs Capital Management LP Q2 2017 Filing
Filed August 14, 2017
Portfolio Value
$2.0B
Holdings
148
Report Date
Q2 2017
Filing Type
13F-HR
All Holdings (148 positions)
| Stock | Value |
|---|---|
—TESARO INC | $68.6M |
ACHCACADIA HEALTHCARE COMPANY IN | $66.7M |
—AETNA INC NEW | $58.9M |
UNHUNITEDHEALTH GROUP INC | $58.2M |
ALXNALEXION PHARMACEUTICALS INC | $56.3M |
PCRXPACIRA PHARMACEUTICALS INC | $49.7M |
MRKMERCK & CO INC | $48.6M |
CICIGNA CORPORATION | $45.2M |
ISRGINTUITIVE SURGICAL INC | $44.9M |
—RADIUS HEALTH INC | $41.2M |
—ALLERGAN PLC | $37.9M |
—SPARK THERAPEUTICS INC | $37.3M |
—GW PHARMACEUTICALS PLC | $36.6M |
MDTMEDTRONIC PLC | $35.5M |
WCGEURWELLCARE HEALTH PLANS INC | $35.5M |
PRAHPRA HEALTH SCIENCES INC | $34.7M |
—ADVANCED ACCELERATOR APPLIC | $32.8M |
HUMHUMANA INC | $31.9M |
CELGCELGENE CORP | $31.8M |
PENPENUMBRA INC | $27.2M |
—MEDICINES CO | $26.4M |
TBPHTHERAVANCE BIOPHARMA INC | $23.9M |
JNJJOHNSON & JOHNSON | $23.2M |
—LOXO ONCOLOGY INC | $23.1M |
COLLCOLLEGIUM PHARMACEUTICAL INC | $22.5M |
EWEDWARDS LIFESCIENCES CORP | $22.5M |
—ALMOST FAMILY INC | $22.3M |
GILDGILEAD SCIENCES INC | $22.2M |
INCYINCYTE CORP | $21.8M |
CLVSEURCLOVIS ONCOLOGY INC | $21.7M |
—MERSANA THERAPEUTICS INC | $21.3M |
NBIXNEUROCRINE BIOSCIENCES INC | $19.3M |
JAZZJAZZ PHARMACEUTICALS PLC | $19.2M |
TMOTHERMO FISHER SCIENTIFIC INC | $19.2M |
HOLXHOLOGIC INC | $19.1M |
DHRDANAHER CORP DEL | $19.0M |
—WRIGHT MED GROUP N V | $18.4M |
MOHMOLINA HEALTHCARE INC | $18.2M |
BCRUSDBARD C R INC | $18.2M |
—EPIZYME INC | $17.7M |
AMRNAMARIN CORP PLC | $17.1M |
GLPGGALAPAGOS NV | $16.9M |
PRTAPROTHENA CORP PLC | $16.8M |
VRTXVERTEX PHARMACEUTICALS INC | $16.6M |
PBYIPUMA BIOTECHNOLOGY INC | $16.3M |
WTWWILLIS TOWERS WATSON PUB LTD | $16.0M |
—PORTOLA PHARMACEUTICALS INC | $15.7M |
EXASEXACT SCIENCES CORP | $15.5M |
—PARATEK PHARMACEUTICALS INC | $14.5M |
BIIBBIOGEN INC | $14.4M |
—AVEXIS INC | $14.4M |
BAXBAXTER INTL INC | $13.9M |
—HEALTHSOUTH CORP | $12.8M |
ACRSACLARIS THERAPEUTICS INC | $11.9M |
ONCBEIGENE LTD | $11.9M |
NVTA1EURINVITAE CORP | $11.5M |
—RTI SURGICAL INC | $11.4M |
—AUDENTES THERAPEUTICS INC | $11.4M |
BMRNBIOMARIN PHARMACEUTICAL INC | $11.4M |
—DERMIRA INC | $11.3M |
—RA PHARMACEUTICALS INC | $11.2M |
ARDXARDELYX INC | $10.2M |
RAREULTRAGENYX PHARMACEUTICAL IN | $10.0M |
CHRSCOHERUS BIOSCIENCES INC | $10.0M |
—INTERSECT ENT INC | $9.6M |
FGENEURFIBROGEN INC | $9.0M |
ASNDASCENDIS PHARMA A S | $9.0M |
MDGLMADRIGAL PHARMACEUTICALS INC | $8.8M |
CLSDUSDCLEARSIDE BIOMEDICAL INC | $8.5M |
—THERAPEUTICSMD INC | $8.4M |
ALNYALNYLAM PHARMACEUTICALS INC | $8.4M |
—CHINA CORD BLOOD CORP | $8.3M |
ASMBASSEMBLY BIOSCIENCES INC | $8.1M |
IM8NINSMED INC | $8.0M |
—ACHILLION PHARMACEUTICALS IN | $7.9M |
REGNREGENERON PHARMACEUTICALS | $7.9M |
—RETROPHIN INC | $7.8M |
—BIOHAVEN PHARMACTL HLDG CO L | $7.7M |
AM6AMICUS THERAPEUTICS INC | $7.6M |
—OBSEVA SA | $7.2M |
—NEURODERM LTD | $7.1M |
—KITE PHARMA INC | $7.0M |
SRPTSAREPTA THERAPEUTICS INC | $6.9M |
WBAWALGREENS BOOTS ALLIANCE INC | $6.7M |
—JUNO THERAPEUTICS INC | $6.7M |
LXRXLEXICON PHARMACEUTICALS INC | $6.5M |
MRUSMERUS N V | $6.4M |
AXGNAXOGEN INC | $6.3M |
—AIMMUNE THERAPEUTICS INC | $6.0M |
—FIVE PRIME THERAPEUTICS INC | $5.9M |
—STERIS PLC | $5.9M |
—NABRIVA THERAPEUTICS PLC | $5.5M |
GTHXEURG1 THERAPEUTICS INC | $5.4M |
—CARDIOME PHARMA CORP | $5.4M |
—MEDICINES CO | $5.3M |
SGENEURSEATTLE GENETICS INC | $5.2M |
CRVSCORVUS PHARMACEUTICALS INC | $5.1M |
—EGALET CORP | $5.0M |
TTPHEURTETRAPHASE PHARMACEUTICALS I | $5.0M |
ACADACADIA PHARMACEUTICALS INC | $4.9M |
Page 1 of 2Next